Similarly, several studies using ICOSL transfected solid tumor cell lines showed that ICOSL contributes to tumor regression via CD8+ cytotoxic lymphocyte-mediated pathways (Liu et al., 2001; Wallin et al., 2001). This evidence concerns the gene CD8A and neoplasm.